110 related articles for article (PubMed ID: 19287958)
1. Functional characterization of p53 in nasopharyngeal carcinoma by stable shRNA expression.
Sun Y; Yi H; Yang Y; Yu Y; Ouyang Y; Yang F; Xiao Z; Chen Z
Int J Oncol; 2009 Apr; 34(4):1017-27. PubMed ID: 19287958
[TBL] [Abstract][Full Text] [Related]
2. Identification of the proteins related to p53-mediated radioresponse in nasopharyngeal carcinoma by proteomic analysis.
Zeng GQ; Yi H; Li XH; Shi HY; Li C; Li MY; Zhang PF; Feng XP; Wan XX; Qu JQ; Xu Y; Sun Y; Chen ZC; Xiao ZQ
J Proteomics; 2011 Nov; 74(12):2723-33. PubMed ID: 21356337
[TBL] [Abstract][Full Text] [Related]
3. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis.
Sun Y; Yi H; Zhang PF; Li MY; Li C; Li F; Peng F; Feng XP; Yang YX; Yang F; Xiao ZQ; Chen ZC
FEBS Lett; 2007 Jan; 581(1):131-9. PubMed ID: 17184779
[TBL] [Abstract][Full Text] [Related]
4. Stable knockdown of ZBTB7A promotes cell proliferation and progression in nasopharyngeal carcinoma.
Liu F; Tang F; Lan J; Jiao W; Si Y; Lu W; Mo M; Li B; Lu J; Wei J; Qin Y; Xiao R; Zhang B; Wang Y; Xiong W
Tumori; 2018; 104(1):37-42. PubMed ID: 29699474
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63.
Chow SE; Wang JS; Chuang SF; Chang YL; Chu WK; Chen WS; Chen YW
Cancer Gene Ther; 2010 Dec; 17(12):872-82. PubMed ID: 20725098
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA Highly Upregulated in Liver Cancer Activates p53-p21 Pathway and Promotes Nasopharyngeal Carcinoma Cell Growth.
Jiang X; Liu W
DNA Cell Biol; 2017 Jul; 36(7):596-602. PubMed ID: 28445086
[TBL] [Abstract][Full Text] [Related]
7. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2.
Gong Z; Zhang S; Zeng Z; Wu H; Yang Q; Xiong F; Shi L; Yang J; Zhang W; Zhou Y; Zeng Y; Li X; Xiang B; Peng S; Zhou M; Li X; Tan M; Li Y; Xiong W; Li G
PLoS One; 2014; 9(11):e110674. PubMed ID: 25422887
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
Yang H; Zhao R; Lee MH
Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
[TBL] [Abstract][Full Text] [Related]
9. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Cao Q; Zhang J; Zhang T
Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
[TBL] [Abstract][Full Text] [Related]
10. Vimentin is a crucial target for anti-metastasis therapy of nasopharyngeal carcinoma.
Wang W; Yi M; Zhang R; Li J; Chen S; Cai J; Zeng Z; Li X; Xiong W; Wang L; Li G; Xiang B
Mol Cell Biochem; 2018 Jan; 438(1-2):47-57. PubMed ID: 28744809
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
[TBL] [Abstract][Full Text] [Related]
12. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
Yi C; Wang Q; Wang L; Huang Y; Li L; Liu L; Zhou X; Xie G; Kang T; Wang H; Zeng M; Ma J; Zeng Y; Yun JP
Oncogene; 2012 Oct; 31(41):4421-33. PubMed ID: 22249270
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells.
Long Z; Wang B; Tao D; Huang Y; Tao Z
Int J Mol Med; 2014 Nov; 34(5):1388-94. PubMed ID: 25231528
[TBL] [Abstract][Full Text] [Related]
14. FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.
Song Y; Zhou X; Bai W; Ma X
Tumour Biol; 2015 Jun; 36(6):4197-202. PubMed ID: 25586348
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma.
Chak WP; Lung RW; Tong JH; Chan SY; Lun SW; Tsao SW; Lo KW; To KF
Mol Carcinog; 2017 Mar; 56(3):1041-1054. PubMed ID: 27597634
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
17. In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.
Wang M; Liu G; Shan GP; Wang BB
Cancer Biother Radiopharm; 2017 Aug; 32(6):193-203. PubMed ID: 28820634
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin.
Xie SM; Fang WY; Liu Z; Wang SX; Li X; Liu TF; Xie WB; Yao KT
J Transl Med; 2008 Oct; 6():55. PubMed ID: 18834541
[TBL] [Abstract][Full Text] [Related]
19. Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma.
Li J; Guo M; Chen L; Chen Z; Fu Y; Chen Y
Cell Death Dis; 2024 Jan; 15(1):35. PubMed ID: 38212344
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for human nasopharyngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model.
Ren SP; Wang L; Wang H; Wu B; Han Y; Wang LS; Wu CT
Cancer Biother Radiopharm; 2008 Oct; 23(5):591-602. PubMed ID: 18999931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
